SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-370478
Filing Date
2013-09-18
Accepted
2013-09-18 16:45:55
Documents
5
Period of Report
2013-09-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d599583d8k.htm 8-K 24938
2 EX-3.1 d599583dex31.htm EX-3.1 71845
3 EX-4.1 d599583dex41.htm EX-4.1 6828
4 EX-5.1 d599583dex51.htm EX-5.1 10119
5 EX-10.1 d599583dex101.htm EX-10.1 148308
  Complete submission text file 0001193125-13-370478.txt   263328
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 131103946
SIC: 2834 Pharmaceutical Preparations